Primary hyperparathyroidism (PHPT) during pregnancy is associated with significant maternal and fetal risks. Prompt diagnosis and effective management during pregnancy can improve both maternal and fetal outcomes. However, there is no consensus with regard to conservative versus surgical management especially in the first and third trimester. We report three cases of PHPT associated with pregnancy that underwent parathyroidectomy each in a different trimester. Cases 1 and 2 were found to have hypercalcaemia and elevated parathyroid hormone levels in the second and first trimesters, respectively. Case 3 was known to have PHPT prenatally but previously declined parathyroidectomy. All three cases underwent parathyroidectomies during pregnancy without significant postoperative complications and all achieved favourable maternal and neonatal outcomes. Maternal hyperparathyroidism represents a preventable cause of maternal morbidity, with fetal morbidity and mortality. The benefits of parathyroidectomy with normalization of serum calcium in the mothers outweigh the risks of hypercalcaemia and suppression of the fetal parathyroid, especially where maternal vitamin D concentration is low.
CarellaMJ, GossainVV. Hyperparathyroidism and pregnancy. Case report & review. J Gen Inter Med1992;7:448–53
2.
PottsJT. Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. In: BraunwaldE, FauciAS, KasperDL, eds. Harrison's Principles of Internal Medicine. 15th edn. New York: McGraw-Hill, 2001:2205–14
3.
FriedrichsenC. Hypocalcamie bei einem Brustkingund Hypercalcamie bei der Mutter. Monatsshr F Kinderheilkunde1938;75:146
4.
KohlmeierL, MarcusR. Calcium disorders of pregnancy. Endocrinol Metab Clin N Am1995;24:15–39
KondoY, NagaiH, KasaharaK, KanazawaK. Primary hyperparathyroidism and acute pancreatitis during pregnancy. Report of a case and a review of the English and Japanese literature. Int J Pancreatol1998;24:43–7
7.
FleischmanAR. Fetal parathyroid gland and calcium homeostasis. Clin Obstet Gynaeocol1980;23:791–802
8.
KovacsCS, LanskeB, HunzelmanJL, GuoJ, KaraplisAC, KronenbergHM. Parathyroid-hormone related peptide regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Nat Acad Sci USA1996;93:15233–8
De SwietM. Medical Disorders in Obstetric Practice. 4th edn. Oxford: Blackwell Scientific, 2002. Chapter 14
11.
JohnstoneREII, KreindlerT, JohnstoneRE. Hyperparathyroidism during pregnancy. Obstet Gynecol1972;40:580
12.
KovacsCS, KronenburgHM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium and lactation. Endocrinol Rev1997;18:832–72
13.
LudwigGD. Hyperparathyroidism in relation to pregnancy. New Engl J Med1962;267:637–42
14.
DelmonicoFL, NeerRM, CosimiAB, BarnesAB, RussellPS. Hyperparathyroidism during pregnancy. Am J Surg1976;131:328–37
15.
ShangoldMM, DorN, WeltSI, FleischmanAR, CrenshawC. Hyperparathyroidism and pregnancy: a review. Obstet Gynaeocol Surv1982;37:217–28
16.
GrahamEM, FreedmanLJ, ForouzanI. Intrauterine growth retardation in a woman with primary hyperparathyroidism. A case report. J Reprod Med1998;43:451–4
17.
KellyTR. Primary hyperparathyroidism during pregnancy. Surgery1991;110:1028–34
18.
BeattieGC, RaviNR, LewisM, Rare presentation of maternal primary hyperparathyroidism. Br Med J2000;321:223–4
19.
TsengUF, ShuSG, ChenCH, ChiCS. Transient neonatal hypoparathyroidism: report of four cases. Acta Paediatr Taiwan2001;42:359–62
20.
IpP. Neonatal convulsion revealing maternal hyperparathyroidism: an unusual case of late neonatal hypoparathyroidism. Arch Gynecol Obstet2003;268:227–9
21.
BruceJ, StrongJA. Maternal hyperparathyroidism and parathyroid deficiency in the child. Q J Med1955;96:307–19
22.
KortKC, SchillerHJ, NumannPJ. Hyperparathyroidism and pregnancy. Am J Surg1999;177:66–8
HigginsRV, HisleyJC. Primary hyperparathyroidism in pregnancy. A report of two cases. J Reprod Med1988;33:726–30
29.
ClarkD, SeedsJW, CefaloRC. Hyperparathyroid crisis and pregnancy. Am J Obstet Gynaecol1981;140:840–2
30.
PatlasN, GolombG, YaffeP, Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology1999;60: 68–73
31.
DjokanovicN, Klieger-GrossmannC, KorenG. Does treatment with bisphosphonates endanger the human pregnancy?J Obstet Gynaecol Canada2008;30:1146–8
32.
MurrayJA, NewmanWA, DarcusJV. Hyperparathyroidism in pregnancy: diagnostic dilemma?Obstet Gynaeocol Surv1997;52:202–5
33.
United States Food and Drugs Administration. See http://www.fda.gov/ohrms/dockets/dailys/00/mar00/032300/cp0001.pdf (last checked 28 January 2010)
34.
British National Formulary. British Medical Association and The Royal Pharmaceutical Society of Great Britain. Issue no 58 (September 2009). Appendix A: Pregnancy
35.
MontoroMN, ColleaJV, MestmanJH. Management of hyperparathyroidism in pregnancy with oral phosphate therapy. Obstet Gynaecol1980;55:431–4
36.
NormanJ, PolitzD, PolitzP. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol2009;71:104–9
37.
PothiwalaP, LevineSN. Parathyroid surgery in pregnancy: review of the literature and localisation by aspiration for parathyroid hormone levels. J Perinatol2009;29:779–84
38.
McGillJ, SturgeonC, KaplanSP, ChiuB, KaplanEL, AngelosP.How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies. J Am Coll Surg2008;207:246–9
